Clin2
NCT07527572Possibly a fitNot yet recruiting

Trial of a probiotic to prevent repeat bacterial vaginosis

Vaginosis, BacterialBacterial VaginosisBacterial Vaginosis (BV)

Part of Infections, Women’s health & pregnancy clinical trials.

This study tests whether a vaginal probiotic called Gyntima Balance can help prevent bacterial vaginosis from coming back. If you have had repeat infections, this might be a way to reduce future episodes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
160 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be a woman between 18 and 45 years old and still having periods.
  • You have had at least 3 episodes of bacterial vaginosis in the past year, with at least one in the last 6 months.
  • You currently have active bacterial vaginosis (confirmed by a doctor with a swab test).
  • You are not pregnant or breastfeeding, and you are not on hormonal birth control.
  • You have a body mass index (BMI) between 18.5 and 32.0, and you do not smoke.
  • You are not currently taking antibiotics, probiotics, or other vaginal treatments, and you have no other vaginal or urinary infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04771728Recruiting· Phase 4
Probiotics added to treatment for bacterial vaginosis

This study tests whether adding probiotics to standard care helps treat bacterial vaginosis (BV) and possibly lowers the chance of it coming back. You would be placed into a study group to compare probiotic treatment with the other approach.

Shenzhen, Guangdong
NCT07483671Not yet recruiting· Phase 2
Vaginal capsule plus antibiotic for bacterial vaginosis

This trial tests a new vaginal capsule called BPR-101, given together with the antibiotic metronidazole, to treat bacterial vaginosis (BV). If you have BV, this study aims to see if the combination is safe and effective in clearing the infection.

Tianjin
NCT07481955Recruiting· Phase 2
A study of chlorhexidine and metronidazole plus FB301 for bacterial vaginosis

This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.

Berlin, State of Berlin
NCT07875673Not yet recruiting· Phase 1
New study for treating bacterial vaginosis

This study tests two new investigational drugs to treat bacterial vaginosis. It aims to see if these drugs are safe and work well. If you have BV, this trial could give you access to a new treatment option.

Sydney, New South Wales
NCT06659380Recruiting
Probiotic for postmenopausal women with vaginal infection

This trial is testing a probiotic (friendly bacteria) treatment for postmenopausal women who have bacterial vaginosis. It aims to see if the probiotic can improve vaginal health.

Kendari, South East Sulawesi
NCT06725888Recruiting
Vagitab-T for bacterial vaginosis

This study tests a medical device called Vagitab-T as an extra treatment for women with bacterial vaginosis who are already taking the antibiotic metronidazole. It may help prevent the infection from coming back.

Timișoara, Timiș County

Hear when a new Bacterial Vaginosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.